Short Interest in Ambu A/S (OTCMKTS:AMBBY) Decreases By 50.0%

Ambu A/S (OTCMKTS:AMBBY) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the November 30th total of 200 shares. Based on an average trading volume of 400 shares, the short-interest ratio is presently 0.3 days.

Ambu A/S Price Performance

Shares of AMBBY stock remained flat at $13.02 during mid-day trading on Friday. 16 shares of the stock traded hands, compared to its average volume of 678. Ambu A/S has a twelve month low of $13.02 and a twelve month high of $22.65. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.47 and a current ratio of 2.49. The company has a market capitalization of $3.06 billion and a P/E ratio of 108.50. The stock’s 50-day moving average price is $16.20 and its two-hundred day moving average price is $18.48.

Ambu A/S Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, December 23rd. Shareholders of record on Friday, December 6th were issued a $0.0557 dividend. The ex-dividend date of this dividend was Friday, December 6th. Ambu A/S’s payout ratio is currently 16.67%.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.